SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-24-043388
Filing Date
2024-11-01
Accepted
2024-11-01 17:30:59
Documents
14

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 556381
2 ex4-5.htm EX-4.5 125260
3 ex4-6.htm EX-4.6 118978
4 ex4-7.htm EX-4.7 123064
5 ex5-1.htm EX-5.1 19057
6 ex10-23.htm EX-10.23 66985
7 ex10-24.htm EX-10.24 297452
8 ex23-1.htm EX-23.1 4124
9 forms-1_001.jpg GRAPHIC 75413
10 forms-1_002.jpg GRAPHIC 700964
11 forms-1_003.jpg GRAPHIC 142431
12 forms-1_004.jpg GRAPHIC 393138
13 ex5-1_001.jpg GRAPHIC 20134
14 ex5-1_002.jpg GRAPHIC 10144
  Complete submission text file 0001493152-24-043388.txt   3159555
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-282781 | Film No.: 241420150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)